You maintain full medical oversightPlexusDx operates as a bridge between you and licensed physicians, not a replacement for ongoing care
One of the most promising treatments we offer is Semaglutide GLP-1, a glucagon-like peptide-1 (GLP-1) receptor agonist that has shown exceptional effectiveness in facilitating weight loss for overweight or obese adults
Similar to Wegovy coverage is limited to states that include obesity-indicated GLP-1s and, more recently, to its sleep apnea indication in some states
Some patients note that weight loss from semaglutide therapy reduces overall inflammatory stress on joints and muscles, which may help with fibromyalgia symptom intensity
For Wegovy (higher-dose semaglutide for weight management), rates were higher, affecting approximately 29.3% of patients across the STEP clinical trials, with most cases occurring during dose escalation phases